Neochem Bio Solutions opened higher at ₹113.00, compared with its previous close of ₹111.00. During today's session, the stock has traded between ₹107.00 and ₹113.00, with an average traded price of ₹110.13. It is currently showing a downward intraday trend.
return calculator
Time Period
An investment of ₹10,000 made 1 year ago in Neochem Bio Solutions is now worth
₹ 9,571.00
resulting in a loss of
₹ 429.00 (4.29%)
invest now
Note: Past profits do not guarantee future returns.
Analyst Overview
No analyst rating data available.
Markets Today
Today's Change
-4.00 (-3.60%)
Day High
₹113.00
Day Low
₹107.00
Day Open
₹113.00
Prev Close
₹111.00
Volume
15,600
Value Traded
₹0.17 Cr
1W Return
2.20%
1M Return
4.75%
3M Return
17.52%
6M Return
52.86%
1Y Return
-4.29%
Fundamentals
Market Cap (₹ Cr.)
183
PE Ratio
-
PB Ratio
2.41
Dividend Yield
-
ROE
39.24%
ROCE
39.40%
Book Value (₹)
46.05
Face Value (₹)
10.00
EPS (TTM)
-
Industry PE
-
Beta
-
Debt to Equity
-
Investment Returns
1 Week
2.20%
6 Week
-
1 Month
4.75%
3 Month
17.52%
9 Month
35.44%
Financials
Yearly
Consolidated
All values in ₹ crores
0.62
Mar 24
0.86
Mar 25
Share Holding Pattern
Promoter66.72%
FII0.18%
DII15.82%
Retails & Others10.93%
Updates
30Jul
Neochem Bio Solutions Promoter Acquires 6,000 Equity Shares on Market, Raises Stake to 54.70%
Neochem Bio Solutions Limited disclosed a promoter share purchase under SEBI PIT Regulations, with Swapnil Rameshbhai Makati acquiring 6,000 equity shares on July 28, 2026, via an open market transaction on the NSE valued at ₹5,44,560. His shareholding rose from 93,59,675 shares (54.67%) to 93,65,675 shares (54.70%) following the purchase. The disclosure was filed by Whole Time Director Hemangini Swapnil Dathia in compliance with Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. No derivative transactions were reported as part of this filing.
2mo ago
28May
Neochem Bio Solutions FY26 revenue rises 32% to INR110.7 crore
Neochem Bio Solutions Limited reported a 32% year-on-year increase in revenue from operations to INR110.7 crore for FY26. Profit after tax surged 62% to INR12 crore, driven by a favorable product mix and higher capacity utilization. EBITDA margins expanded by 321 basis points to 20.4%.
4mo ago
21May
Neochem Bio FY26 PAT rises 62% to ₹1,203 lakh
Neochem Bio Solutions Limited reported a 62% increase in PAT to ₹1,203 lakh for FY26, with revenue growing 32% to ₹11,069 lakh. EBITDA increased 48% to ₹2,193 lakh, supported by a 52.7% capacity utilization. The Board approved the audited results on May 18, 2026, and an earnings call is scheduled for May 22, 2026.
